VerifyRecall
Alerts
RECALL RECORD — CLASS IIRecall closedF-0841-2020/FDA enforcement
Les Chateaux De France·Food·Feb 25, 2020

Butterfly Shrimp 16/20, 50 lb

What you need to know

Class II

  • What happened

    During a routine inspection, FDA identified the coconut ingredient in the firm's coconut shrimp had undeclared sodium metabisulfite

  • Health risk

    The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. An allergen that is present but missing or incorrect on the label can cause a serious reaction in allergic consumers.

  • Action required

    Do not eat the product if you or someone in your household has a diagnosed allergy. Check the codes below, return it to the retailer for a refund, or dispose of it safely. Seek urgent care for signs of a severe allergic reaction.

Recall closed · classified by the FDANV, FL, NY, PA +4 moreMore food

Advertisement

Ad

Know someone who bought this?

A quick share can keep a pantry check from becoming a missed warning.

Share via WhatsApp

Match before you discard

Product identification

Source: FDA FOOD

Brand nameLes Chateaux De France
Recalling firmLes Chateaux De FranceInwood, NY, United States
UPC / barcodesNo UPC listed in the FDA enforcement record.
Lot / date codes
  • 2-20-20 2-13-20 1-30-20
Distribution area
NVFLNYPALANJAZMA

NV, FL, NY, PA, LA, NJ, AZ, MA

United States

Quantity affected803 boxes
Recall initiationFDA report date: March 18, 2020
FDA recall numberF-0841-2020

Beyond the headline

The recall, in context

Les Chateaux De France initiated this food recall on February 25, 2020. The FDA enforcement report states: During a routine inspection, FDA identified the coconut ingredient in the firm's coconut shrimp had undeclared sodium metabisulfite. The FDA report lists distribution as: NV, FL, NY, PA, LA, NJ, AZ, MA.

The FDA enforcement report describes the reason as: During a routine inspection, FDA identified the coconut ingredient in the firm's coconut shrimp had undeclared sodium metabisulfite

Butterfly Shrimp 16/20, 50 lb was made or distributed by Les Chateaux De France in Inwood, NY, United States. This page reflects FDA report F-0841-2020, dated March 18, 2020.

Why this is a Class II recall

Class II means the product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. In this recall, an allergen that is present but missing or incorrect on the label can cause a serious reaction in allergic consumers.

FDA definition

The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote.

What to do now

  1. 1

    Stop using it

    Do not eat, drink or take the affected product.

  2. 2

    Check the codes

    Compare the lot and date codes against the table above.

  3. 3

    Return or discard

    Contact the retailer or recalling firm about a refund, and dispose of the product safely.

Consumer safety guide

Undeclared allergen

Symptoms to watch for

Hives, swelling, wheezing, coughing, vomiting, abdominal pain or a drop in blood pressure. Anaphylaxis is a medical emergency.

When symptoms may appear

Allergic reactions often begin within minutes to a few hours of eating the allergen.

Higher-risk groups

Anyone with a diagnosed food allergy, especially children, and people with a history of anaphylaxis or asthma.

What to do now

  1. 1Do not eat or serve the affected product if you or anyone in the household has a diagnosed allergy.
  2. 2If symptoms such as swelling, wheezing or breathing difficulty occur, use the person's prescribed emergency plan and call emergency services.
  3. 3Keep the packaging, contact the retailer or manufacturer for a refund, and read the official recall notice for the exact allergen.

For a severe allergic reaction, do not wait for a callback or refund process before seeking emergency care.

This is general consumer safety information, not medical advice or a diagnosis. Follow the official recall notice and contact a healthcare professional if you have concerns about exposure or symptoms.

Frequently asked

Questions about this recall

What is the Butterfly Shrimp 16/20, 50 lb recall?

Les Chateaux De France recalled Butterfly Shrimp 16/20, 50 lb in an FDA Class II enforcement action reported as F-0841-2020. During a routine inspection, FDA identified the coconut ingredient in the firm's coconut shrimp had undeclared sodium metabisulfite

What should I do if I bought this product?

Do not eat the product if you or someone in your household has a diagnosed allergy. Check the codes below, return it to the retailer for a refund, or dispose of it safely. Seek urgent care for signs of a severe allergic reaction. Do not eat or serve the affected product if you or anyone in the household has a diagnosed allergy. If symptoms such as swelling, wheezing or breathing difficulty occur, use the person's prescribed emergency plan and call emergency services. Keep the packaging, contact the retailer or manufacturer for a refund, and read the official recall notice for the exact allergen.

Is the Les Chateaux De France recall still active?

The FDA lists this recall as recall closed. It remains relevant if you still have the affected product or need to identify a historical recall.

Where can I verify this recall?

This page is normalized from the openFDA enforcement record F-0841-2020. You can verify it directly using the official source link on this page. VerifyRecall updates its index from public FDA enforcement data and does not replace advice from the FDA, the recalling firm or a healthcare professional.

Verify before you act.

VerifyRecall is independent and not affiliated with the FDA. Always confirm the latest status on the official source record.

Official source

Related alerts

Recent Undeclared allergens recalls

All alerts
Class I·

Oliva on Main

Riad's Oliva to Go Spicy Baba Ghanouj

Contains undeclared sesame

MA, CTFood
Class I·

Oliva on Main

Riad's Oliva to Go Baba Ghanouj

Contains undeclared sesame

MA, CTFood

Record last synced from official openFDA enforcement data on November 14, 2026. Source record: official FDA notice.